Data / Research funding / Washington / Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center: 470 NIH awards ($1.5B) and 2 NSF awards ($319.8K), fiscal years 2021 to 2026
Fred Hutchinson Cancer Center in Seattle, WA is funded under 470 NIH awards ($1.5B) and 2 NSF awards ($319.8K) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- TJFZLPP6NYL6
- State
- Washington
Awards
472 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| HIV Vaccines Clinical Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $244,071,463 | June 29, 2006 | November 30, 2027 | COREY, LAWRENCE | reporter.nih.gov |
| HIV Vaccine Trials Network Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $177,480,054 | June 29, 2006 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| SDMC: HIV Vaccine Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $156,744,802 | June 29, 2006 | November 30, 2027 | GILBERT, PETER B. | reporter.nih.gov |
| HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $74,729,762 | June 29, 2006 | November 30, 2027 | DONNELL, DEBORAH J | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2022 to 2025 | $44,496,290 | January 1, 1997 | December 31, 2029 | LYNCH, THOMAS JAMES | reporter.nih.gov |
| THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE NHLBI FUNDING FROM THE WOMEN'S HEALTH INITIATIVE (WHI) - CLINICAL COORDINATING CENTER (CCC). | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $36,880,325 | February 1, 2021 | January 31, 2026 | ANDERSON, GARNET L. | reporter.nih.gov |
| The Early Detection Research Network: Data Management and Coordinating Center | NIH | National Cancer Institute | 2021 to 2025 | $34,727,768 | April 14, 2000 | July 31, 2027 | ZHENG, YINGYE | reporter.nih.gov |
| SWOG Statistics & Data Management Center complex - extension supplement for GY06 | NIH | National Cancer Institute | 2022 to 2025 | $34,480,720 | April 17, 2014 | February 28, 2026 | LEBLANC, MICHAEL L. | reporter.nih.gov |
| MOSAAIC Cognitive Assessment Reading Center Administrative Supplement | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $18,523,030 | August 15, 2023 | July 31, 2026 | ANDERSON, GARNET L. | reporter.nih.gov |
| SEER*EDUCATE BASE AWARD | NIH | National Cancer Institute | 2022 to 2025 | $16,160,319 | September 17, 2024 | August 16, 2026 | SCHWARTZ, STEPHEN | reporter.nih.gov |
| Adult Leukemia Research Center | NIH | National Cancer Institute | 2021 to 2025 | $14,957,447 | August 28, 1997 | July 31, 2029 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| The Pacific Northwest Prostate Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $9,924,776 | September 19, 2002 | August 31, 2028 | NELSON, PETER S | reporter.nih.gov |
| 1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,010,367 | September 16, 2020 | August 31, 2025 | BOECKH, MICHAEL J | reporter.nih.gov |
| Fred Hutchinson Cancer Center Lung SPORE | NIH | National Cancer Institute | 2021 to 2025 | $7,947,641 | August 1, 2019 | July 31, 2030 | HOUGHTON, A MCGARRY | reporter.nih.gov |
| Upgrading Institutional Capacity with a BSL-3 Facility for Multidisciplinary Biomedical Research | NIH | Office of the Director, National Institutes of Health | 2025 | $7,947,160 | September 15, 2025 | March 31, 2028 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| Seattle Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $7,698,581 | February 1, 2007 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| Understanding adenoma progression: Interplay among tissue microenvironment, clonal architecture, and gut microbiome | NIH | National Cancer Institute | 2022 to 2025 | $7,696,898 | September 20, 2022 | August 31, 2027 | GRADY, WILLIAM MALLORY | reporter.nih.gov |
| Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge | NIH | National Cancer Institute | 2021 to 2025 | $7,671,117 | April 12, 1999 | February 28, 2027 | SANDMAIER, BRENDA MARIE | reporter.nih.gov |
| NCI Cancer Screening Research Network: Coordinating and Communication Center | NIH | National Cancer Institute | 2024 to 2025 | $7,230,152 | February 9, 2024 | December 31, 2027 | ANDERSON, GARNET L. | reporter.nih.gov |
| Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,655,353 | January 30, 2023 | December 31, 2027 | STAMATATOS, LEONIDAS | reporter.nih.gov |
| Polygenic Risk Scores for Diverse Populations - Bridging Research and Clinical Care | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,401,936 | August 20, 2020 | July 31, 2025 | KOOPERBERG, CHARLES L | reporter.nih.gov |
| 2/2 Partnership for the Advancement of Cancer Research: NMSU & Fred Hutch | NIH | National Cancer Institute | 2021 to 2025 | $6,226,431 | September 30, 2007 | August 31, 2028 | SIMON, JULIAN | reporter.nih.gov |
| Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center | NIH | National Cancer Institute | 2021 to 2025 | $5,784,232 | September 18, 2019 | July 31, 2026 | MADELEINE, MARGARET M | reporter.nih.gov |
| Physical Activity to Improve CV Health in Older Women: A Pragmatic Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $5,255,718 | September 15, 2020 | August 31, 2025 | KOOPERBERG, CHARLES L | reporter.nih.gov |
| Fecal Microbiota Transplantation and Fiber for the Treatment of Graft-versus-host Disease After Hematopoietic Cell Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,128,451 | September 1, 2023 | June 30, 2027 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Translational Research Program in Cancer Differences across Populations | NIH | National Cancer Institute | 2024 to 2025 | $5,031,369 | September 1, 2024 | August 31, 2029 | PETERS, ULRIKE | reporter.nih.gov |
| CANOE Partnership: Cancer Awareness, Navigation, Outreach, and Equitable Indigenous Health Outcomes | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $5,025,129 | September 21, 2024 | May 31, 2029 | NELSON, LONNIE A. | reporter.nih.gov |
| The role and mechanism of alternative RNA splice variants and gene fusions as drivers of cancer | NIH | National Cancer Institute | 2021 to 2025 | $4,965,167 | September 21, 2021 | August 31, 2028 | HOLLAND, ERIC C. | reporter.nih.gov |
| Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies | NIH | National Cancer Institute | 2022 to 2025 | $4,722,849 | June 16, 2022 | May 31, 2027 | PAULOVICH, AMANDA G | reporter.nih.gov |
| Development of Innovative Resources to Advance MDS Research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $4,661,966 | September 15, 2023 | July 31, 2028 | BLEAKLEY, MARIE | reporter.nih.gov |
| Mechanisms of transcriptional regulation and transcription factor specificity | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $4,486,284 | May 1, 2021 | March 16, 2026 | HAHN, STEVEN M | reporter.nih.gov |
| Modeling Precision Interventions for Prostate Cancer Control | NIH | National Cancer Institute | 2021 to 2025 | $4,423,369 | June 15, 2025 | August 31, 2026 | ETZIONI, RUTH D | reporter.nih.gov |
| Life and Longevity After Cancer (LILAC): The Women's Health Initiative Cancer Survivor Cohort | NIH | National Cancer Institute | 2021 to 2023 | $4,365,371 | February 15, 2013 | August 31, 2025 | ANDERSON, GARNET L. | reporter.nih.gov |
| Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy | NIH | National Cancer Institute | 2025 | $4,234,248 | September 19, 2025 | August 31, 2029 | WARREN, EDUS HOUSTON | reporter.nih.gov |
| Combining Targeted RIT and Synergistic Novel Agent-Renewal | NIH | National Cancer Institute | 2021 to 2025 | $3,984,924 | June 1, 2020 | May 31, 2027 | OROZCO, JOHNNIE JOSE | reporter.nih.gov |
| Molecular analysis of genetic recombination and DNA break repair | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,900,469 | May 1, 2016 | April 30, 2027 | SMITH, GERALD R | reporter.nih.gov |
| Modeling and analytics for cancer diagnostics: traversing the data-evidence divide | NIH | National Cancer Institute | 2022 to 2025 | $3,872,365 | September 1, 2022 | August 31, 2029 | ETZIONI, RUTH D | reporter.nih.gov |
| Fred Hutchinson Breast Cancer Clinical Validation Center | NIH | National Cancer Institute | 2022 to 2025 | $3,773,783 | August 16, 2010 | July 31, 2027 | LI, CHRISTOPHER I | reporter.nih.gov |
| Clinical translation of a NexGen platform for quantifying protein networks in human biospecimens | NIH | National Cancer Institute | 2021 to 2025 | $3,727,397 | July 18, 2019 | June 30, 2029 | PAULOVICH, AMANDA G | reporter.nih.gov |
| Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus | NIH | National Cancer Institute | 2022 to 2025 | $3,642,526 | August 5, 2022 | July 31, 2027 | GRADY, WILLIAM MALLORY | reporter.nih.gov |
| Genetics, Epigenetics, and Risk Prediction for Esophageal Adenocarcinoma | NIH | National Cancer Institute | 2022 to 2025 | $3,588,780 | September 12, 2022 | August 31, 2027 | KOOPERBERG, CHARLES L | reporter.nih.gov |
| Assessing the effects of oral pre-exposure prophylaxis on pharmacokinetics of monoclonal and vaccine-induced antibodies among women vulnerable to HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,554,273 | September 12, 2025 | August 31, 2029 | HUANG, YUNDA | reporter.nih.gov |
| Preventing GVHD by inhibition of alloantigen presentation in the gut | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,543,040 | July 1, 2019 | June 30, 2027 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial | NIH | National Cancer Institute | 2023 to 2025 | $3,532,837 | September 20, 2023 | August 31, 2028 | BRICKER, JONATHAN B | reporter.nih.gov |
| SALSA - Study of Active Lifestyle Activation | NIH | National Cancer Institute | 2021 to 2025 | $3,527,531 | September 21, 2021 | August 31, 2026 | CHOW, ERIC JESSEN | reporter.nih.gov |
| Nutrition and Physical Activity Assessment Study (NPAAS) | NIH | National Cancer Institute | 2021 to 2025 | $3,492,459 | July 12, 2006 | June 30, 2028 | NEUHOUSER, MARIAN L | reporter.nih.gov |
| Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) | NIH | National Cancer Institute | 2024 to 2025 | $3,477,537 | February 12, 2024 | December 31, 2027 | KOOPERBERG, CHARLES L | reporter.nih.gov |
| Fast and flexible Bayesian phylogenetics via modern machine learning | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,455,144 | July 1, 2021 | June 30, 2027 | MATSEN, FREDERICK ALBERT | reporter.nih.gov |
| The MYC Transcription Factor Network and the Path to Cancer | NIH | National Cancer Institute | 2021 to 2024 | $3,449,610 | September 1, 2018 | August 31, 2025 | EISENMAN, ROBERT NEIL | reporter.nih.gov |
| Career Development in Pediatric and Medical Oncology | NIH | National Cancer Institute | 2021 to 2025 | $3,314,336 | September 30, 1997 | August 31, 2026 | MESHINCHI, SOHEIL | reporter.nih.gov |
| Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research | NIH | National Cancer Institute | 2021 to 2023 | $3,239,571 | September 20, 2019 | August 31, 2025 | LIN, DANIEL W. | reporter.nih.gov |
| Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $3,203,990 | December 6, 2018 | November 30, 2024 | STAMATATOS, LEONIDAS | reporter.nih.gov |
| Molecular mechanisms and functions of global chromatin control | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $3,180,654 | January 1, 2021 | February 28, 2026 | TSUKIYAMA, TOSHIO | reporter.nih.gov |
| Hematopoietic Stem Cell And Cord Blood Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,169,146 | September 30, 2005 | May 31, 2030 | PETERSDORF, EFFIE W | reporter.nih.gov |
| A Patient-Centric Approach to Advance Functional Precision Oncology | NIH | National Cancer Institute | 2023 to 2025 | $3,167,628 | September 22, 2023 | August 31, 2028 | KEMP, CHRISTOPHER J | reporter.nih.gov |
| Identifying vulnerabilities in the long-lived HIV reservoir to accelerate its decay | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,158,764 | April 1, 2025 | March 31, 2028 | DUERR, ANN C | reporter.nih.gov |
| Cancer Immunotherapy Trials Network Central Operations and Statistical Center | NIH | National Cancer Institute | 2021 to 2022 | $2,997,769 | September 22, 2010 | August 31, 2023 | DAVIDSON, NANCY ELLEN | reporter.nih.gov |
| Stem Cell and Transplantation Biology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,984,057 | August 1, 2015 | July 31, 2028 | STIREWALT, DEREK L | reporter.nih.gov |
| Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Cell Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,966,978 | December 1, 2021 | November 30, 2026 | CHENG, GUANG-SHING | reporter.nih.gov |
| Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC) | NIH | National Cancer Institute | 2021 to 2025 | $2,944,568 | September 17, 2018 | August 31, 2028 | FENG, ZIDING | reporter.nih.gov |
| Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment | NIH | National Cancer Institute | 2023 to 2025 | $2,860,531 | June 5, 2023 | May 31, 2028 | PAULOVICH, AMANDA G | reporter.nih.gov |
| Telephone Delivered Acceptance & Commitment Therapy for Weight Loss | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,838,616 | July 1, 2020 | June 30, 2026 | BRICKER, JONATHAN B | reporter.nih.gov |
| Interdisciplinary Epidemiologic Consortium to Investigate T-cell Response in Colorectal Cancer | NIH | National Cancer Institute | 2021 to 2025 | $2,822,799 | May 1, 2020 | October 31, 2026 | PETERS, ULRIKE | reporter.nih.gov |
| Translating the tumor regulome from cell-free DNA for precision oncology | NIH | National Cancer Institute | 2022 to 2025 | $2,812,871 | September 1, 2025 | August 31, 2027 | HA, GAVIN | reporter.nih.gov |
| Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,806,788 | December 1, 2016 | July 31, 2027 | PRLIC, MARTIN | reporter.nih.gov |
| Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy | NIH | National Cancer Institute | 2023 to 2025 | $2,766,158 | September 1, 2023 | August 31, 2028 | HILL, JOSHUA AIDEN | reporter.nih.gov |
| Early and Reinfection in High Risk Women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $2,760,723 | September 15, 1995 | February 28, 2026 | OVERBAUGH, JULIE M. | reporter.nih.gov |
| Base-Edited Hematopoietic Stem and Progenitor Cells To Enable Safe Use Of Highly Potent CD33-Targeted Radioimmunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $2,758,516 | July 1, 2022 | June 30, 2027 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| In Vivo Gene Editing of B cells with NICE-AAV Vectors | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,735,041 | December 16, 2021 | November 30, 2026 | PETERSON, CHRISTOPHER W | reporter.nih.gov |
| Novel Approaches to CD33-Directed Radioimmunotherapy | NIH | National Cancer Institute | 2022 to 2025 | $2,717,065 | December 1, 2024 | November 30, 2026 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Clonal Hematopoiesis in the Women's Health Initiative | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,701,565 | July 15, 2019 | March 31, 2028 | REINER, ALEXANDER P | reporter.nih.gov |
| Clinical Significance of MHC Haplotypes in HCT | NIH | National Cancer Institute | 2021 to 2025 | $2,687,420 | March 1, 2003 | August 31, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma | NIH | National Cancer Institute | 2021 to 2025 | $2,686,770 | August 1, 2021 | July 31, 2026 | NEWELL, EVAN | reporter.nih.gov |
| In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,680,549 | June 8, 2022 | April 1, 2025 | ADAIR, JENNIFER EILEEN | reporter.nih.gov |
| Advancing equity in colorectal cancer genetic risk prediction through expansion of racial/ethnic minority representation | NIH | National Cancer Institute | 2021 to 2024 | $2,661,057 | July 1, 2020 | June 30, 2025 | PETERS, ULRIKE | reporter.nih.gov |
| An integrative omics approach to investigate gene-environment interaction in colorectal cancer risk | NIH | National Cancer Institute | 2023 to 2025 | $2,659,982 | June 1, 2023 | May 31, 2028 | PETERS, ULRIKE | reporter.nih.gov |
| Genetic and molecular basis for SRSF2 mutations in myelodysplasia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,659,317 | August 1, 2015 | April 30, 2029 | BRADLEY, ROBERT K | reporter.nih.gov |
| Improving Outcomes Assessment in Chronic Graft versus Host Disease | NIH | National Cancer Institute | 2022 to 2025 | $2,646,165 | July 18, 2007 | March 31, 2027 | LEE, STEPHANIE J | reporter.nih.gov |
| HIV-CRISPR: A novel approach to the comprehensive discovery of HIV latency factors | NIH | National Institute on Drug Abuse | 2022 to 2024 | $2,640,000 | April 15, 2020 | June 30, 2025 | EMERMAN, MICHAEL | reporter.nih.gov |
| Development of 211Astatine-Conjugated Anti-CD45 Antibody-Based Conditioning for Hematopoietic Stem Cell Gene Therapy and Editing | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,608,434 | May 15, 2020 | April 30, 2026 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Adipocyte-Derived Lipid and Mitochondrial Signals in Neuroprotectionand Brain Senescence | NIH | National Institute on Aging | 2025 | $2,586,818 | September 15, 2025 | August 31, 2029 | RAJAN, AKHILA | reporter.nih.gov |
| Targeted genetic engineering of B cells to induce protective antibody responses to viral pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,577,835 | July 5, 2022 | June 30, 2027 | ADAIR, JENNIFER EILEEN | reporter.nih.gov |
| Developing Durable, Env-Boosted CAR T Cells for HIV Cure | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,557,695 | November 2, 2022 | October 31, 2027 | PETERSON, CHRISTOPHER W | reporter.nih.gov |
| Training Program in Infectious Diseases in the Immunocompromised Host | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,532,332 | August 1, 2016 | July 31, 2026 | BOECKH, MICHAEL J | reporter.nih.gov |
| Human Papillomavirus and Polyomavirus Associated Malignancies. | NIH | National Cancer Institute | 2021 to 2023 | $2,515,952 | September 15, 2017 | August 31, 2024 | GALLOWAY, DENISE A. | reporter.nih.gov |
| Developing macrophage reprogramming mRNA nanocarriers for initial clinical testing | NIH | National Cancer Institute | 2021 to 2024 | $2,491,070 | April 1, 2022 | July 31, 2025 | STEPHAN, MATTHIAS | reporter.nih.gov |
| Modulation of signaling from damage-associated molecular patterns to improve radiation-induced thymic dysfunction | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,418,442 | July 18, 2022 | May 31, 2027 | DUDAKOV, JARROD | reporter.nih.gov |
| Experimental-data-based in-silico data generation platform to improve the accuracy and reliability of single-cell and spatial omics data analysis | NIH | National Human Genome Research Institute | 2025 | $2,409,233 | September 19, 2025 | August 31, 2029 | LI, JINGYI JESSICA | reporter.nih.gov |
| Promoting T cell reconstitution after hematopoietic cell transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,391,092 | January 1, 2024 | December 31, 2030 | DUDAKOV, JARROD | reporter.nih.gov |
| Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,388,492 | February 1, 2023 | January 31, 2028 | STRONG, ROLAND K | reporter.nih.gov |
| Quit2Heal: Rigorous Randomized Trial of a Smartphone Application to Help Cancer Patients Stop Smoking | NIH | National Cancer Institute | 2021 to 2024 | $2,383,412 | June 1, 2020 | May 31, 2026 | BRICKER, JONATHAN B | reporter.nih.gov |
| Using a SMART design to evaluate remotely delivered, community-aligned weight loss interventions among breast cancer survivors | NIH | National Cancer Institute | 2023 to 2025 | $2,377,399 | July 1, 2023 | June 30, 2028 | GREENLEE, HEATHER | reporter.nih.gov |
| Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,357,606 | September 1, 2022 | August 31, 2027 | LASTWIKA, KRISTIN J | reporter.nih.gov |
| Molecular basis and protective efficacy of cross-neutralizing antibodies against four major respiratory viruses | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,206 | March 16, 2023 | February 29, 2028 | BOONYARATANAKORNKIT, JIM | reporter.nih.gov |
| Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit | NIH | National Cancer Institute | 2023 to 2025 | $2,336,400 | September 22, 2023 | August 31, 2028 | ZHENG, YINGYE | reporter.nih.gov |
| PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research | NIH | National Cancer Institute | 2021 to 2023 | $2,327,659 | September 20, 2013 | July 31, 2025 | TANGEN, CATHERINE M. | reporter.nih.gov |
| Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality | NIH | National Cancer Institute | 2021 to 2024 | $2,315,110 | September 3, 2018 | January 31, 2026 | SORROR, MOHAMED | reporter.nih.gov |
| Biologic correlatives of chronic GVHD onset | NIH | National Cancer Institute | 2021 to 2023 | $2,309,532 | July 2, 2019 | June 30, 2025 | LEE, STEPHANIE J | reporter.nih.gov |
| Molecular Interplay of Endocytic Proteins | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,253,644 | February 15, 2020 | April 30, 2030 | BAI, JIHONG | reporter.nih.gov |
| Defining Protective CMV Immunity after Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,244,070 | February 6, 2023 | January 31, 2028 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Rational in situ programming of cancer vaccine-responding T-cell clones | NIH | National Cancer Institute | 2021 to 2025 | $2,219,015 | July 1, 2021 | June 30, 2026 | STEPHAN, MATTHIAS | reporter.nih.gov |
| Multiplex base/prime editors for in vivo selection of modified HSPCs in hemoglobinopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,218,334 | January 17, 2017 | December 31, 2025 | KIEM, HANS-PETER | reporter.nih.gov |
| Forecasting influenza evolution on a heterogeneous immune landscape | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,197,907 | February 15, 2022 | January 31, 2028 | BEDFORD, TREVOR BC | reporter.nih.gov |
| Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer | NIH | National Cancer Institute | 2022 to 2025 | $2,185,961 | April 1, 2021 | March 31, 2026 | BERGER, ALICE | reporter.nih.gov |
| The role of the senescent microenvironment on cancer initiating cells in the colon. | NIH | National Institute on Aging | 2021 to 2025 | $2,183,637 | September 30, 2021 | August 31, 2026 | GRADY, WILLIAM MALLORY | reporter.nih.gov |
| Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study | NIH | National Cancer Institute | 2022 to 2024 | $2,178,209 | January 1, 2020 | December 31, 2025 | HILL, JOSHUA AIDEN | reporter.nih.gov |
| Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia | NIH | National Cancer Institute | 2023 to 2025 | $2,151,498 | August 1, 2023 | July 31, 2028 | BRADLEY, ROBERT K | reporter.nih.gov |
| Mechanisms and consequence of helical shape generation in Helicobacter pylori | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,129,854 | June 1, 2018 | February 28, 2029 | SALAMA, NINA | reporter.nih.gov |
| Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation | NIH | National Cancer Institute | 2022 to 2024 | $2,125,273 | April 1, 2020 | March 31, 2026 | BRICKER, JONATHAN B | reporter.nih.gov |
| Health and Financial Costs of Unequal Care: Colorectal Cancer as a Case Study | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $2,119,031 | September 23, 2023 | March 31, 2028 | RUTTER, CAROLYN M | reporter.nih.gov |
| Hutchinson Center as Lead Academic Participating Site (UG1) | NIH | National Cancer Institute | 2022 to 2025 | $2,098,511 | March 6, 2019 | February 28, 2026 | YU, EVAN | reporter.nih.gov |
| Integrative Genomics into Genetic Association Studies of Blood Pressure and Stroke in African Americans | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,098,023 | April 1, 2022 | March 31, 2026 | HSU, LI | reporter.nih.gov |
| Immuno and Epigenetics of Hematopoietic Cell Transplantation | NIH | National Cancer Institute | 2021 to 2025 | $2,093,460 | August 1, 2017 | April 30, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| D4Z4 Coding Transcripts and FSHD | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,082,296 | September 1, 1998 | December 31, 2026 | TAPSCOTT, STEPHEN J | reporter.nih.gov |
| Blending deep learning with probabilistic mechanistic models to predict and understand the evolution and function of adaptive immune receptors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,068,943 | June 1, 2019 | May 31, 2026 | MATSEN, FREDERICK ALBERT | reporter.nih.gov |
| Statistical Methods for Efficacy Trials of Vaccines and Monoclonal Antibodies Against Genetically-Diverse Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,067,031 | April 1, 2003 | June 30, 2029 | GILBERT, PETER B. | reporter.nih.gov |
| Deep molecular and cellular profiling of colorectal cancer tumor and immune microenvironment in Alaska Native people | NIH | National Cancer Institute | 2023 to 2025 | $2,066,819 | May 25, 2023 | April 30, 2028 | HUYGHE, JEROEN R | reporter.nih.gov |
| Determinants of response to cancer immunotherapy | NIH | National Cancer Institute | 2024 to 2025 | $2,058,822 | August 1, 2024 | July 31, 2028 | FONG, LAWRENCE | reporter.nih.gov |
| Breastmilk antibodies regulate neonatal immunity to the microbiota | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,049,282 | February 1, 2023 | January 31, 2028 | KOCH, MEGHAN ANNE | reporter.nih.gov |
| Regulation of Proteasome Capacity | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $2,041,286 | August 3, 2021 | May 31, 2027 | LEHRBACH, NICOLAS JOHN | reporter.nih.gov |
| Mechanism of modulation of intestinal immune responses by dietary signals | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,032,015 | August 22, 2022 | July 31, 2027 | TALBOT, JHIMMY | reporter.nih.gov |
| Pathways to Cancer Research Renewal | NIH | National Cancer Institute | 2021 to 2025 | $2,030,050 | September 19, 2017 | August 31, 2027 | CHOWNING, JEANNE TING | reporter.nih.gov |
| Scalable multi-mode education to increase use of ITCR tools by diverse analysts | NIH | National Cancer Institute | 2022 to 2024 | $2,025,865 | September 1, 2020 | August 31, 2026 | LEEK, JEFFREY T. | reporter.nih.gov |
| Role of necrosis in the evolution of highly metastatic and chemo-resistant breast cancers | NIH | National Cancer Institute | 2023 to 2025 | $2,015,238 | August 23, 2023 | July 31, 2028 | CHEUNG, KEVIN JON | reporter.nih.gov |
| HPC & GPU Resources for AI/ML Augmented Biomedical Research | NIH | Office of the Director, National Institutes of Health | 2025 | $2,000,000 | July 15, 2025 | July 14, 2027 | SANDERS, WILLIAM SHANE | reporter.nih.gov |
| Genetic requirements of Helicobacter pylori infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,992,451 | December 1, 2003 | January 31, 2027 | SALAMA, NINA | reporter.nih.gov |
| Molecular and Cellular Mechanisms of Wound Repair | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,939,679 | May 1, 2015 | July 31, 2026 | PARKHURST, SUSAN M | reporter.nih.gov |
| Molecular modeling and machine learning for protein structures and interactions | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,920,577 | June 1, 2021 | May 31, 2027 | BRADLEY, PHILIP | reporter.nih.gov |
| Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,920,168 | August 9, 2019 | July 31, 2025 | MCGUIRE, ANDREW | reporter.nih.gov |
| Differentiation balances oncogene-driven proliferation to maintain epidermal homeostasis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,892,446 | July 27, 2017 | June 30, 2028 | BERONJA, SLOBODAN | reporter.nih.gov |
| Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,886,759 | August 23, 2016 | May 31, 2026 | BEDFORD, TREVOR BC | reporter.nih.gov |
| Defining cellular states of quiescence in human brain tumors | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,865,171 | February 15, 2021 | November 30, 2026 | PADDISON, PATRICK | reporter.nih.gov |
| Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,841,358 | August 1, 2023 | July 31, 2028 | LAMPE, PAUL D. | reporter.nih.gov |
| Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning among Advanced Cancer Patients | NIH | National Cancer Institute | 2021 to 2025 | $1,840,400 | September 1, 2025 | August 31, 2027 | SHEN, MEGAN JOHNSON | reporter.nih.gov |
| Planar cell polarity control of axon guidance | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,830,188 | August 1, 2023 | July 31, 2027 | MOENS, CECILIA B | reporter.nih.gov |
| Evaluating a Multilevel Communication Campaign to Increase HIV Vaccine Trial Enrollment | NIH | National Institute of Mental Health | 2023 to 2025 | $1,828,286 | May 19, 2023 | April 1, 2025 | ANDRASIK, MICHELE PEAKE | reporter.nih.gov |
| Extrinsic regulation of primitive, myeloid-biased hematopoietic stem cells by Semaphorin 4a | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,820,724 | January 1, 2021 | December 31, 2026 | SILBERSTEIN, LEV | reporter.nih.gov |
| Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level | NIH | National Cancer Institute | 2021 to 2023 | $1,820,103 | May 9, 2019 | April 30, 2025 | PHIPPS, WARREN | reporter.nih.gov |
| Statistical methods for analyzing objectively measured physical activity. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,810,549 | July 1, 2016 | June 30, 2027 | DI, CHONGZHI | reporter.nih.gov |
| Immunogenetics of Outcomes Disparities After Allogeneic HCT | NIH | National Cancer Institute | 2021 to 2025 | $1,797,736 | May 15, 2023 | April 30, 2028 | PETERSDORF, EFFIE W | reporter.nih.gov |
| Cellular mechanisms governing nutrient sensing and organismal energy homeostasis | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,795,066 | September 11, 2017 | July 31, 2027 | RAJAN, AKHILA | reporter.nih.gov |
| Regulation of Protein Synthesis by Synonymous Codon Usage | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $1,793,612 | September 9, 2016 | May 31, 2027 | SUBRAMANIAM, ARVIND RASI | reporter.nih.gov |
| Translational Research Program in Colorectal Cancer Disparities | NIH | National Cancer Institute | 2021 to 2022 | $1,784,468 | September 1, 2020 | August 31, 2024 | PETERS, ULRIKE | reporter.nih.gov |
| Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors | NIH | National Cancer Institute | 2021 to 2024 | $1,762,638 | May 1, 2020 | April 30, 2026 | EISENMAN, ROBERT NEIL | reporter.nih.gov |
| Understanding metabolic functions of mitochondria in proliferating cells | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,760,000 | August 1, 2022 | May 31, 2027 | SULLIVAN, LUCAS BRYAN | reporter.nih.gov |
| The Molecular Basis for Integrin-Mediated Bidirectional Signaling | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,760,000 | September 1, 2022 | June 30, 2027 | CAMPBELL, MELODY G | reporter.nih.gov |
| Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes | NIH | National Cancer Institute | 2023 to 2025 | $1,755,220 | September 19, 2023 | August 31, 2028 | HA, GAVIN | reporter.nih.gov |
| Phylodynamic mechanisms of HIV reservoir seeding and maintenance | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,745,561 | September 16, 2024 | July 31, 2029 | REEVES, DANIEL | reporter.nih.gov |
| Cross talk between keratinocytes and skin-resident T-cells influences HSV recurrence | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,744,756 | July 12, 2024 | June 30, 2029 | ZHU, JIA | reporter.nih.gov |
| Characterizing determinants of primary KSHV infection among children and adolescents in Uganda | NIH | National Cancer Institute | 2021 to 2023 | $1,735,566 | September 13, 2019 | August 31, 2025 | PHIPPS, WARREN | reporter.nih.gov |
| Addressing Cancer-Related Financial Hardship through Delivery of a Proactive Financial Navigation Intervention | NIH | National Cancer Institute | 2022 to 2025 | $1,734,275 | April 16, 2020 | March 31, 2027 | SHANKARAN, VEENA | reporter.nih.gov |
| Improving CAR-T efficacy against solid tumors by expanding lymph node reservoirs of “stem-like” CAR-T cells | NIH | National Cancer Institute | 2023 to 2025 | $1,734,139 | July 1, 2023 | June 30, 2028 | SRIVASTAVA, SHIVANI | reporter.nih.gov |
| Role of local antibodies in control of chronic genital herpes | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,727,127 | February 5, 2024 | December 31, 2028 | SHOLUKH, ANTON M | reporter.nih.gov |
| Neutrophil derived proteinases abolish the IFNG signature in NSCLC | NIH | National Cancer Institute | 2023 to 2025 | $1,713,513 | July 7, 2023 | June 30, 2028 | HOUGHTON, A MCGARRY | reporter.nih.gov |
| A new humanized mouse model to study HBV gene editing | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,705,880 | August 1, 2024 | July 31, 2029 | JEROME, KEITH R | reporter.nih.gov |
| Computational Modeling of Lineage Decisions using Single-cell Data | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,703,755 | September 17, 2022 | July 31, 2027 | SETTY, MANU N | reporter.nih.gov |
| Transcriptional-translational conflict in bladder epithelial homeostasis and cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,697,731 | January 1, 2023 | December 31, 2027 | HSIEH, ANDREW CALEB | reporter.nih.gov |
| Data analysis tools for leveraging massive public data to improve hypothesis-driven research | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,692,770 | April 1, 2022 | February 28, 2027 | LEEK, JEFFREY T. | reporter.nih.gov |
| Characterizing Immunogenetics in Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,691,810 | April 1, 2023 | March 31, 2027 | ZHAO, LUE PING | reporter.nih.gov |
| Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings | NIH | National Cancer Institute | 2023 to 2025 | $1,685,549 | August 1, 2023 | July 31, 2028 | TRIPLETTE, MATTHEW ADAM | reporter.nih.gov |
| Statistical Methods for Inferring Gene-Phenotype Associations Using Omic Data from Gene Knockout and Human Phenotype Studies | NIH | National Human Genome Research Institute | 2023 to 2025 | $1,667,392 | September 22, 2023 | June 30, 2028 | SUN, WEI | reporter.nih.gov |
| Novel synthetic receptors with improved antigen specificity and specificity for cancer therapy | NIH | National Cancer Institute | 2022 to 2025 | $1,664,746 | April 1, 2005 | December 31, 2026 | RIDDELL, STANLEY R. | reporter.nih.gov |
| Exploring the epigenetic control of pancreatic cancer subtypes | NIH | National Cancer Institute | 2021 to 2025 | $1,661,284 | July 1, 2024 | June 30, 2027 | KUGEL, SITA | reporter.nih.gov |
| Statistical Methods for RNA-seq Data Analysis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,660,762 | May 15, 2014 | July 31, 2027 | SUN, WEI | reporter.nih.gov |
| Biophysical and structural studies of protein and enzyme mechanism, evolution, and engineering | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,642,666 | June 1, 2023 | May 31, 2028 | STODDARD, BARRY L. | reporter.nih.gov |
| Deep Learning-based Protein Design of HIV-1 Env GP120 Core Immunogens for CD4 Binding Site Germline Targeting | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,604,893 | February 16, 2024 | January 31, 2028 | PANCERA, MARIE | reporter.nih.gov |
| Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia | NIH | National Institute on Aging | 2024 to 2025 | $1,595,708 | August 15, 2024 | June 30, 2029 | JONES, SALENE M. W. | reporter.nih.gov |
| Identifying and understanding drivers of chemoresistance in small cell lung cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,594,869 | July 1, 2023 | June 30, 2028 | MACPHERSON, DAVID | reporter.nih.gov |
| Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity | NIH | National Cancer Institute | 2022 to 2025 | $1,582,219 | July 1, 2022 | June 30, 2027 | NELSON, PETER S | reporter.nih.gov |
| Exploring novel SRC-regulated pathways in IDH mutant intrahepatic cholangiocarcinoma | NIH | National Cancer Institute | 2022 to 2025 | $1,574,167 | April 1, 2021 | March 31, 2027 | KUGEL, SITA | reporter.nih.gov |
| Defining and characterizing microenvironmental drivers of disseminated tumor cell dormancy in brain | NIH | National Cancer Institute | 2021 to 2024 | $1,572,835 | May 5, 2020 | April 30, 2026 | GHAJAR, CYRUS M | reporter.nih.gov |
| Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,563,164 | December 20, 2019 | November 30, 2025 | KIEM, HANS-PETER | reporter.nih.gov |
| Investigating chromatin mechanisms using viral systems | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,558,857 | September 1, 2019 | July 31, 2029 | AVGOUSTI, DAPHNE CHRISTINA | reporter.nih.gov |
| Deciphering long-term virus evolution through the reconstruction of past viral genomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,551,984 | August 17, 2023 | July 31, 2028 | BLANCO-MELO, DANIEL | reporter.nih.gov |
| ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation | NIH | National Institute on Drug Abuse | 2022 to 2023 | $1,549,914 | September 15, 2022 | November 30, 2024 | HEFFNER, JAIMEE | reporter.nih.gov |
| Hormone signaling and translation control in advanced prostate cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,542,779 | December 1, 2023 | November 30, 2025 | HSIEH, ANDREW CALEB | reporter.nih.gov |
| Molecular dissection of glia-neuron interactions | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,537,995 | September 30, 2020 | August 31, 2025 | SINGHVI, AAKANKSHA | reporter.nih.gov |
| Defining Critical Sites of Vulnerability and Correlates of Protection to Kaposi Sarcoma Associated Herpesvirus to Inform Vaccine Design | NIH | National Cancer Institute | 2024 to 2025 | $1,535,738 | August 1, 2024 | July 31, 2029 | MCGUIRE, ANDREW | reporter.nih.gov |
| Leveraging metabolomics to identify factors contributing to health disparities in Native Hawaiian individuals | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,532,102 | May 1, 2024 | April 30, 2029 | DARST, BURCU FRANCES | reporter.nih.gov |
| Examination of factors influencing the racial disparity in fibroid incidence | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,523,924 | August 1, 2024 | April 30, 2029 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Statistical Methods for Network-based Integrative Analysis of Microbiome Data | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $1,482,502 | September 20, 2022 | July 31, 2027 | MA, JING | reporter.nih.gov |
| Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,471,281 | May 1, 2024 | March 31, 2029 | SCHIFFER, JOSHUA TISDELL | reporter.nih.gov |
| Coordinating Center for Population-based Research to Optimize Cancer Screening (PROSPR) (U24) | NIH | National Cancer Institute | 2022 to 2023 | $1,464,869 | April 15, 2018 | March 31, 2026 | LI, CHRISTOPHER I | reporter.nih.gov |
| Chemotherapy-driven evolution of the vascular secretome and its role in therapeutic resistance | NIH | National Cancer Institute | 2022 to 2025 | $1,453,364 | January 1, 2021 | December 31, 2025 | GHAJAR, CYRUS M | reporter.nih.gov |
| Functional and molecular basis of ineffective erythropoiesis in SF3B1-mutant myelodysplastic syndromes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,444,574 | June 1, 2020 | May 31, 2025 | BRADLEY, ROBERT K | reporter.nih.gov |
| Role of tumor cell cluster-induced signaling in breast cancer metastasis | NIH | National Cancer Institute | 2022 to 2025 | $1,440,208 | December 1, 2024 | November 30, 2026 | CHEUNG, KEVIN JON | reporter.nih.gov |
| PPE Request | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $1,438,731 | May 2, 2023 | April 30, 2024 | COREY, LAWRENCE | reporter.nih.gov |
| A compass for those with relapsed leukemia after transplant | NIH | National Cancer Institute | 2024 to 2025 | $1,435,661 | June 1, 2024 | May 31, 2026 | FURLAN, SCOTT NICHOLAS | reporter.nih.gov |
| Pediatric Oncology Research Training Program | NIH | National Cancer Institute | 2021 to 2025 | $1,429,762 | August 1, 1979 | June 30, 2027 | MESHINCHI, SOHEIL | reporter.nih.gov |
| SMCHD1 Pathways as Candidate Targets for FSHD | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $1,429,596 | April 25, 2014 | June 30, 2025 | TAPSCOTT, STEPHEN J | reporter.nih.gov |
| The Fbw7 ubiquitin ligase network: normal and neoplastic functions | NIH | National Cancer Institute | 2023 to 2025 | $1,427,939 | June 1, 2023 | May 31, 2028 | CLURMAN, BRUCE E | reporter.nih.gov |
| Cellular mechanisms of nucleocytoplasmic export through Nuclear Envelope Budding | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,422,796 | August 3, 2021 | June 30, 2026 | PARKHURST, SUSAN M | reporter.nih.gov |
| Targeting PLK1 signaling for the treatment of fibrolamellar carcinoma | NIH | National Cancer Institute | 2023 to 2025 | $1,415,175 | August 1, 2023 | July 31, 2028 | GUJRAL, TARAN SINGH | reporter.nih.gov |
| Augmenting PSMA expression to enhance PSMA directed therapeutic efficacy | NIH | National Cancer Institute | 2024 to 2025 | $1,388,233 | February 1, 2024 | January 31, 2029 | HAFFNER, MICHAEL C | reporter.nih.gov |
| Targeting the tumor microenvironment with engineered CD4+ T cells | NIH | National Cancer Institute | 2024 to 2025 | $1,387,760 | August 8, 2024 | July 31, 2029 | VEATCH, JOSHUA R | reporter.nih.gov |
| Targeted Clinical Research Program to Address Selected Viral Infections | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,357,889 | July 1, 2016 | January 2, 2025 | BOECKH, MICHAEL | reporter.nih.gov |
| An INteractive Survivorship Program to Improve Healthcare REsources [INSPIRE] for Adolescent and Young Adult (AYA) Cancer Survivors | NIH | National Cancer Institute | 2024 to 2025 | $1,356,873 | September 18, 2020 | March 31, 2027 | BAKER, KEVIN S | reporter.nih.gov |
| Dormancy-dependent determination of hematopoietic stem cell fate from hemogenic endothelium | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,320,000 | April 1, 2023 | March 31, 2028 | HADLAND, BRANDON K | reporter.nih.gov |
| Mechanistic Characterization of the Replication Stress Response | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,320,000 | August 15, 2023 | May 31, 2028 | ADEYEMI, RICHARD | reporter.nih.gov |
| The role of antibodies in mother to child HIV transmission | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,319,416 | March 1, 2008 | February 28, 2025 | OVERBAUGH, JULIE M. | reporter.nih.gov |
| Understanding efficacy and FE(II)-Promoted Activation of 1,2,4-Trioxolanes in cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,316,613 | April 1, 2021 | May 31, 2027 | COLLISSON, ERIC | reporter.nih.gov |
| Rational Vaccine Design to prevent HIV-Associated Lymphoma | NIH | National Cancer Institute | 2024 to 2025 | $1,312,191 | February 1, 2024 | January 31, 2029 | MCGUIRE, ANDREW | reporter.nih.gov |
| Tissue Regulatory T Cells in Mucosal Infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,309,591 | November 7, 2018 | October 31, 2024 | LUND, JENNIFER M | reporter.nih.gov |
| Statistical Methods for Large Scale Microbiome Studies of Cardiovascular Disease Risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,307,641 | March 15, 2021 | March 31, 2026 | WU, MICHAEL CHIAO-AN | reporter.nih.gov |
| Mathematical modeling of optimal therapeutic combinations for HIV cure | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,302,145 | December 16, 2019 | November 30, 2025 | SCHIFFER, JOSHUA TISDELL | reporter.nih.gov |
| Liquid biopsy of the lung to profile lung cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,300,178 | September 15, 2020 | August 31, 2025 | NAIR, VISWAM SIVA | reporter.nih.gov |
| Molecular pathoepidemiology of contralateral breast cancer | NIH | National Cancer Institute | 2022 | $1,297,113 | March 1, 2017 | August 31, 2025 | MALONE, KATHLEEN E | reporter.nih.gov |
| Translational Science of Gastrointestinal Cancer Initiation and Progression | NIH | National Cancer Institute | 2021 to 2025 | $1,289,608 | September 19, 2018 | August 31, 2028 | YU, MING | reporter.nih.gov |
| Statistical Methods for Advancing HIV Prevention | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,255,054 | March 1, 2023 | February 29, 2028 | GAO, FEI | reporter.nih.gov |
| Regulation of thymic regeneration by GPR39 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,246,342 | September 1, 2022 | December 31, 2023 | DUDAKOV, JARROD | reporter.nih.gov |
| A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancer | NIH | National Cancer Institute | 2022 to 2025 | $1,243,044 | September 19, 2016 | August 31, 2027 | WHITEAKER, JEFF | reporter.nih.gov |
| Par-4 Regulation of Actomyosin Contractility as a Tumor Suppressive Mechanism in Breast Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,241,069 | June 1, 2024 | May 31, 2026 | ALVAREZ, JAMES V | reporter.nih.gov |
| Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,222,090 | April 1, 2024 | February 28, 2029 | STAMATATOS, LEONIDAS | reporter.nih.gov |
| Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer | NIH | National Cancer Institute | 2021 to 2024 | $1,219,521 | August 15, 2020 | April 30, 2025 | NELSON, PETER S | reporter.nih.gov |
| Epigenomic profiling of complex tissues with single-cell CUT&RUN | NIH | National Human Genome Research Institute | 2022 to 2023 | $1,217,769 | April 19, 2019 | February 29, 2024 | HENIKOFF, STEVEN | reporter.nih.gov |
| NRF2 suppression of inflammatory signaling and its role in tumor progression | NIH | National Cancer Institute | 2024 to 2025 | $1,198,472 | July 5, 2024 | June 30, 2026 | ALVAREZ, JAMES V | reporter.nih.gov |
| Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies | NIH | National Cancer Institute | 2023 to 2025 | $1,196,767 | December 1, 2022 | November 30, 2027 | HUANG, YING | reporter.nih.gov |
| Mechanisms underlying chromosome segregation | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,183,910 | September 22, 2023 | July 31, 2028 | BIGGINS, SUSAN | reporter.nih.gov |
| Statistical Methods for Analysis of Tumor Heterogeneity in Genetic Epidemiology | NIH | National Cancer Institute | 2021 to 2023 | $1,166,626 | July 1, 2015 | June 30, 2025 | HSU, LI | reporter.nih.gov |
| Interrogating roles for REST in small cell lung cancer therapy response and resistance | NIH | National Cancer Institute | 2024 to 2025 | $1,164,152 | December 22, 2023 | November 30, 2028 | MACPHERSON, DAVID | reporter.nih.gov |
| Selective mRNA translation in developmental disorders | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,150,816 | June 18, 2020 | May 31, 2025 | BERONJA, SLOBODAN | reporter.nih.gov |
| Causes and consequences of genomic instability in myelodysplasia | NIH | National Cancer Institute | 2024 to 2025 | $1,131,744 | September 1, 2024 | August 31, 2029 | LEE, STANLEY CHUN-WEI | reporter.nih.gov |
| Origin firing at repetitive sequences and genome replication | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $1,114,638 | February 1, 2016 | February 28, 2026 | BEDALOV, ANTONIO | reporter.nih.gov |
| Expanding the cancer paralog genetic interaction map to enable precision oncology | NIH | National Cancer Institute | 2024 to 2025 | $1,111,732 | March 1, 2024 | February 28, 2029 | BERGER, ALICE | reporter.nih.gov |
| Tumor-specific autoantibodies for SCLC early detection | NIH | National Cancer Institute | 2022 to 2024 | $1,111,722 | December 17, 2019 | November 30, 2025 | HOUGHTON, A MCGARRY | reporter.nih.gov |
| Statistical Methods for Prospective Evaluation of Biomarkers | NIH | National Cancer Institute | 2021 to 2024 | $1,103,772 | September 4, 2009 | June 30, 2025 | ZHENG, YINGYE | reporter.nih.gov |
| Acquisition of OrbiTrap Eclipse w/FAIMS mass spectrometer | NIH | Office of the Director, National Institutes of Health | 2022 | $1,100,563 | July 1, 2022 | June 30, 2023 | GAFKEN, PHILIP R | reporter.nih.gov |
| Developing Bioinformatic and Microfluidic Single Cell Methods for Studying Intratumoral Heterogeneity in Acute Myeloid Leukemia | NIH | National Cancer Institute | 2022 to 2023 | $1,094,957 | December 10, 2018 | November 30, 2025 | PAGUIRIGAN, AMY | reporter.nih.gov |
| Dissecting the immunomodulatory effects of NK cells on immune responses to cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,093,243 | September 1, 2024 | August 31, 2029 | BARRY, KEVIN C | reporter.nih.gov |
| Tissue Mechanisms of Aging in the Genetic Model C. elegans | NIH | National Institute on Aging | 2024 to 2025 | $1,024,506 | July 1, 2024 | June 30, 2028 | PRIESS, JAMES R | reporter.nih.gov |
| Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC | NIH | National Cancer Institute | 2022 to 2023 | $1,012,548 | March 8, 2019 | February 29, 2024 | MACPHERSON, DAVID | reporter.nih.gov |
| BMT CTN Core - Fred Hutchinson Cancer Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,009,810 | June 5, 2002 | June 30, 2031 | LEE, STEPHANIE J | reporter.nih.gov |
| Mechanisms of treatment failure in chimeric antigen receptor T cell therapy | NIH | National Cancer Institute | 2022 to 2023 | $979,067 | February 1, 2019 | July 31, 2025 | TILL, BRIAN | reporter.nih.gov |
| Harnessing endogenous mechanisms of thymic regeneration toboost immune function in recipients of hematopoietic cell transplant | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $978,008 | January 1, 2019 | December 31, 2023 | DUDAKOV, JARROD | reporter.nih.gov |
| Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit | NIH | National Cancer Institute | 2021 | $951,279 | June 1, 2017 | May 31, 2023 | PAULOVICH, AMANDA G | reporter.nih.gov |
| Statistical Methods for Enhanced Mapping of Microbiome Relationships | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $926,540 | September 15, 2023 | July 31, 2027 | WU, MICHAEL CHIAO-AN | reporter.nih.gov |
| Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathways | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $925,760 | June 1, 2020 | January 31, 2024 | OVERBAUGH, JULIE M. | reporter.nih.gov |
| Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $908,973 | September 1, 2023 | April 30, 2024 | SCHIFFER, JOSHUA TISDELL | reporter.nih.gov |
| An AHEI Dietary Intervention to Reduce Pain in Women with Endometriosis | NIH | National Institute of Nursing Research | 2021 to 2023 | $897,951 | February 11, 2019 | December 31, 2024 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Actify! An mHealth mood management tool to improve population-level smoking cessation | NIH | National Institute on Drug Abuse | 2025 | $893,044 | September 1, 2025 | July 31, 2030 | HEFFNER, JAIMEE | reporter.nih.gov |
| Complete mapping of immune selection from antibodies to HIV | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $884,813 | December 7, 2018 | November 30, 2025 | BLOOM, JESSE D | reporter.nih.gov |
| Evolution and mechanisms of cytomegalovirus antagonism of host cell defenses | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $880,114 | April 1, 2020 | March 31, 2025 | GEBALLE, ADAM P. | reporter.nih.gov |
| Statistical modeling to support population and translational cancer research | NIH | National Cancer Institute | 2021 to 2025 | $870,818 | September 20, 2017 | August 31, 2028 | GULATI, ROMAN | reporter.nih.gov |
| Selective Targeting of the PD-1+ HIV/SIV reservoir with novel anti-PD-1 chimeric antigen receptor T cells | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $862,398 | August 1, 2025 | July 31, 2030 | EICHHOLZ, KARSTEN | reporter.nih.gov |
| Metabolite- and cytokine-mediated signals interact to control human CD8 T cell responses in tissues | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $857,346 | January 17, 2025 | December 31, 2029 | PRLIC, MARTIN | reporter.nih.gov |
| Radioimmunotherapy Combinations for B-cell Malignancy | NIH | National Cancer Institute | 2022 to 2024 | $855,237 | January 1, 1998 | February 29, 2024 | GREEN, DAMIAN J. | reporter.nih.gov |
| Basal Cell Polarity Proteins in Normal Tissue Homeostasis and Cancer | NIH | National Cancer Institute | 2021 to 2023 | $851,497 | June 7, 2019 | November 30, 2025 | VASIOUKHIN, VALERI | reporter.nih.gov |
| Targeting microbial triggers of gammopathy for immunoprevention | NIH | National Cancer Institute | 2025 | $846,118 | June 13, 2024 | May 31, 2026 | DHODAPKAR, MADHAV V | reporter.nih.gov |
| Identification of Novel Mucosal Immune Mechanisms Involved in Protection from HIV-1 | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $836,591 | June 8, 2017 | May 31, 2024 | LUND, JENNIFER M | reporter.nih.gov |
| Development and Feasibility Testing of a Multi-Component Intervention to Increase HIV Testing and Linkage to Services among MSM in Peru | NIH | National Institute of Mental Health | 2021 to 2025 | $830,166 | July 15, 2021 | November 30, 2026 | LANKOWSKI, ALEXANDER JULIAN | reporter.nih.gov |
| Integrating Genomics and Metabolomics to Develop Predictive Models of Prostate Cancer in Multiethnic Men | NIH | National Cancer Institute | 2022 to 2024 | $830,017 | February 1, 2020 | June 30, 2025 | DARST, BURCU FRANCES | reporter.nih.gov |
| Understanding and predicting relapse in acute myeloid leukemia | NIH | National Cancer Institute | 2022 to 2023 | $819,280 | July 1, 2013 | May 31, 2024 | RADICH, JERALD PATRICK | reporter.nih.gov |
| CD90-targeted nanoparticles for in vivo hematopoietic stem cell gene therapy | NIH | National Heart, Lung, and Blood Institute | 2025 | $814,209 | May 1, 2025 | February 28, 2029 | KIEM, HANS-PETER | reporter.nih.gov |
| Financial and Clinical Outcomes among Commercially-Insured Cancer Patients following the Affordable Care Act | NIH | National Cancer Institute | 2024 to 2025 | $805,200 | July 1, 2024 | June 30, 2028 | RAMSEY, SCOTT D. | reporter.nih.gov |
| Methods for Analyzing Cancer Somatic Mutation Data | NIH | National Cancer Institute | 2021 to 2022 | $805,199 | September 20, 2018 | August 31, 2025 | HE, QIANCHUAN | reporter.nih.gov |
| 2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $801,778 | September 16, 2020 | August 31, 2025 | LEISENRING, WENDY M | reporter.nih.gov |
| Decoding the interactions between T cell receptors and peptide-MHC | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $799,765 | June 20, 2018 | May 31, 2028 | THOMAS, PAUL G. | reporter.nih.gov |
| Short Course in Data Science for Environmental Public Health | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $794,699 | August 25, 2023 | July 31, 2027 | HOFFMAN, AVA MARIE | reporter.nih.gov |
| Mechanisms of Tumor Derived Neutrophil Induced Apoptosis in Lymphocytes | NIH | National Cancer Institute | 2021 to 2022 | $793,523 | July 17, 2018 | June 30, 2023 | HOUGHTON, A MCGARRY | reporter.nih.gov |
| Precision disease prevention via somatic mutagenesis enumeration (PREDICTION) | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $791,053 | September 15, 2018 | September 30, 2023 | HOLLAND, ERIC C. | reporter.nih.gov |
| Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $783,041 | September 24, 2018 | August 31, 2025 | BLOOM, JESSE D | reporter.nih.gov |
| Therapeutic use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial | NIH | National Cancer Institute | 2022 | $780,737 | February 22, 2017 | January 31, 2024 | MADELEINE, MARGARET M | reporter.nih.gov |
| Developing CVD prediction models for women with early stage breast cancer | NIH | National Cancer Institute | 2025 | $777,704 | December 1, 2017 | January 31, 2030 | GREENLEE, HEATHER | reporter.nih.gov |
| Probing human HSC genesis in a flow-directed 3D hemogenic vascular niche model | NIH | National Heart, Lung, and Blood Institute | 2025 | $776,511 | September 1, 2025 | May 31, 2029 | HADLAND, BRANDON K | reporter.nih.gov |
| Targeting macrophages in metastatic cancer | NIH | National Cancer Institute | 2022 to 2023 | $774,841 | February 7, 2019 | January 31, 2024 | RONGVAUX, ANTHONY | reporter.nih.gov |
| ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation | NIH | National Institute on Drug Abuse | 2025 | $772,015 | September 15, 2022 | November 30, 2027 | HEFFNER, JAIMEE | reporter.nih.gov |
| Harnessing Tissue Resident Memory T Cells for Immunotherapy of Herpes Virus Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $770,078 | June 13, 2018 | May 31, 2024 | COREY, LAWRENCE | reporter.nih.gov |
| Anti-CD38 targeted alpha emitter radioimmunotherapy to eliminate multiple myeloma | NIH | National Cancer Institute | 2022 to 2023 | $769,415 | March 8, 2017 | December 31, 2023 | GREEN, DAMIAN J. | reporter.nih.gov |
| Training in Cancer Genomics and Genomic Data Science | NIH | National Cancer Institute | 2022 to 2025 | $768,937 | July 1, 2022 | June 30, 2028 | WARREN, EDUS HOUSTON | reporter.nih.gov |
| ReCAPSE: Recurrence from Claims And PROs for SEER Enhancement | NIH | National Cancer Institute | 2021 to 2022 | $761,612 | September 25, 2017 | December 31, 2024 | ETZIONI, RUTH D | reporter.nih.gov |
| Providing nicotine replacement therapy to enhance the efficacy of a smoking cessation smartphone app for Hispanic adults | NIH | National Cancer Institute | 2025 | $757,913 | February 1, 2025 | January 31, 2030 | BRICKER, JONATHAN B | reporter.nih.gov |
| Topographic mapping by cranial motor neurons | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $751,917 | September 30, 2018 | June 30, 2024 | MOENS, CECILIA B | reporter.nih.gov |
| Developing methods for advancing the early detection of pancreatic ductal adenocarcinoma leveraging electronic medical records data | NIH | National Cancer Institute | 2025 | $739,640 | September 1, 2025 | August 31, 2030 | ZHAO, YINGQI | reporter.nih.gov |
| Peer PrEP referral + HIV self-test for PrEP initiation among young Kenyan women | NIH | National Institute of Mental Health | 2021 to 2024 | $732,972 | September 1, 2023 | August 31, 2025 | ORTBLAD, KATRINA FRANCES | reporter.nih.gov |
| Leveraging telehealth to optimize PrEP and PEP delivery at pharmacies in Kenya | NIH | National Institute of Mental Health | 2025 | $729,286 | September 12, 2025 | June 30, 2030 | ORTBLAD, KATRINA FRANCES | reporter.nih.gov |
| Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy | NIH | National Cancer Institute | 2024 to 2025 | $702,343 | April 1, 2021 | March 31, 2027 | COLLISSON, ERIC | reporter.nih.gov |
| MECHANISMS UNDERLYING OLFACTORY EFFECTS ON APPETITE | NIH | National Institute on Deafness and Other Communication Disorders | 2022 | $697,074 | March 15, 2018 | February 29, 2024 | BUCK, LINDA B | reporter.nih.gov |
| Rapid Acute Leukemia Genomic Profiling with CRISPR enrichment and Real-time long-read sequencing | NIH | National Cancer Institute | 2023 to 2024 | $687,444 | April 1, 2023 | March 31, 2026 | YEUNG, CECILIA C | reporter.nih.gov |
| Targeting a Novel Hematopoietic Stem Cell Population in Non-Human Primates for Effective and Sustained Gene Therapy | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $684,721 | November 10, 2017 | October 31, 2023 | KIEM, HANS-PETER | reporter.nih.gov |
| DLK1 regulates HSC quiescence through phase separation mediated inhibition of receptor signaling | NIH | National Heart, Lung, and Blood Institute | 2025 | $680,321 | May 15, 2025 | February 28, 2029 | BERNSTEIN, IRWIN D | reporter.nih.gov |
| Improving immune modulation for smoldering myeloma | NIH | National Cancer Institute | 2025 | $655,380 | December 1, 2024 | May 31, 2030 | DHODAPKAR, MADHAV V | reporter.nih.gov |
| MAPK-driven kinetochore stress in cancer | NIH | National Cancer Institute | 2025 | $652,799 | April 1, 2025 | March 31, 2030 | PADDISON, PATRICK | reporter.nih.gov |
| Cytomegalovirus-specific Immune Reconstitution after Hematopoietic Cell Transplantation in the Era of Modern Antiviral Prophylaxis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $646,626 | February 7, 2022 | June 30, 2025 | ZAMORA, DANNIEL | reporter.nih.gov |
| THE SYNGENICDNA AND UPOET PLATFORM: OVERCOMING INNATE BARRIERS TO GENETIC ENGINEE | NIH | National Institute of Dental & Craniofacial Research | 2021 | $641,645 | September 8, 2017 | August 31, 2023 | JOHNSTON, CHRISTOPHER D | reporter.nih.gov |
| Statistical Genetics and Genomics for Epidemiologic Research | NIH | National Cancer Institute | 2021 to 2022 | $641,605 | July 17, 2018 | June 30, 2025 | SUN, WEI | reporter.nih.gov |
| PROACT: Promoting Follow-up of Abnormal Colorectal Cancer Screening Tests through Multilevel Interventions | NIH | National Cancer Institute | 2025 | $621,406 | August 1, 2025 | July 31, 2030 | ISSAKA, RACHEL B. | reporter.nih.gov |
| ODOR BLOCKING OF STRESS | NIH | National Institute on Deafness and Other Communication Disorders | 2022 | $618,687 | March 1, 2018 | June 30, 2023 | BUCK, LINDA B | reporter.nih.gov |
| The role of tissue-resident T cells in resolving inflammation of the human oral mucosa | NIH | National Institute of Dental & Craniofacial Research | 2022 | $615,312 | August 8, 2022 | August 7, 2025 | PRLIC, MARTIN | reporter.nih.gov |
| Building independent research leaders in HIV-associated malignancies in Uganda | NIH | Fogarty International Center | 2022 to 2023 | $597,799 | June 1, 2014 | March 31, 2026 | PHIPPS, WARREN | reporter.nih.gov |
| The role of Syndecan-2 in hematopoietic stem cell maintenance and regeneration | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $595,552 | May 1, 2022 | May 21, 2026 | TERMINI, CHRISTINA MARIE | reporter.nih.gov |
| Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository | NIH | National Cancer Institute | 2022 | $595,342 | April 1, 2013 | March 31, 2024 | NEUHOUSER, MARIAN L | reporter.nih.gov |
| Endonuclease-mediated disruption of latent HSV as curative therapy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $592,670 | June 12, 2018 | August 31, 2023 | JEROME, KEITH R | reporter.nih.gov |
| Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $589,260 | September 1, 2023 | March 31, 2024 | STAMATATOS, LEONIDAS | reporter.nih.gov |
| Selective Radionuclide Delivery for Precise Bone Marrow Niche Alterations | NIH | National Cancer Institute | 2023 to 2024 | $583,145 | July 5, 2023 | June 30, 2025 | OROZCO, JOHNNIE JOSE | reporter.nih.gov |
| Therapeutic applications of CD4+ T cells specific for oncogenic driver mutations | NIH | National Cancer Institute | 2022 to 2024 | $582,321 | March 4, 2020 | February 28, 2025 | VEATCH, JOSHUA R | reporter.nih.gov |
| Faceting GEMs (Genomics Education Modules) for the Entry-level Workforce | NIH | National Human Genome Research Institute | 2024 | $579,698 | September 24, 2024 | June 30, 2027 | HOFFMAN, AVA MARIE | reporter.nih.gov |
| Genetic Conflict Shapes Centromeres and Heterochromatin | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $577,198 | July 1, 2005 | May 31, 2025 | MALIK, HARMIT S. | reporter.nih.gov |
| Combined computational and structural studies to create novel macromolecular recognition properties | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $566,892 | April 1, 2021 | December 31, 2023 | STODDARD, BARRY L. | reporter.nih.gov |
| Generating Research Opportunities Within Statistics at Fred Hutch (GROWS@FredHutch) | NIH | National Cancer Institute | 2023 to 2025 | $561,832 | September 1, 2023 | August 31, 2028 | OTHUS, MEGAN | reporter.nih.gov |
| Regulation of Chromosome Segregation | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $561,766 | February 1, 2002 | July 31, 2023 | BIGGINS, SUSAN | reporter.nih.gov |
| The Gut Microbiota and Graft versus Host Disease (GVHD) | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $559,777 | November 9, 2017 | October 31, 2023 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Mechanoregulation of Cell Functions during Embryogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $552,133 | July 20, 2018 | May 31, 2024 | PARKHURST, SUSAN M | reporter.nih.gov |
| Interrogating a novel axis of tumor suppression in small cell lung cancer | NIH | National Cancer Institute | 2025 | $548,915 | December 1, 2024 | November 30, 2029 | MACPHERSON, DAVID | reporter.nih.gov |
| Developing an intervention to improve follow-up of abnormal fecal immunochemical test results in a safety-net population using a mixed methods approach | NIH | National Cancer Institute | 2021 to 2023 | $534,394 | September 1, 2019 | March 31, 2025 | ISSAKA, RACHEL B. | reporter.nih.gov |
| SeattleStatSummer for Biomedical Data Science Research Training | NIH | National Library of Medicine | 2022 to 2025 | $533,360 | September 15, 2022 | August 31, 2027 | OTHUS, MEGAN | reporter.nih.gov |
| Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer | NIH | National Cancer Institute | 2021 to 2024 | $533,245 | February 1, 2024 | August 31, 2024 | NABET, BEHNAM | reporter.nih.gov |
| Enhancing Data Science Skills Through Bio-OCS - Biomedical Open Case Studies | NIH | National Institute of General Medical Sciences | 2025 | $532,276 | July 14, 2025 | April 30, 2030 | WRIGHT, CARRIE | reporter.nih.gov |
| Signaling Pathways that Modulate Neuronal Activity | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $527,764 | January 1, 2020 | March 31, 2030 | BAI, JIHONG | reporter.nih.gov |
| Development and Testing of a Multi-Component Intervention to Support HIV Care Engagement among Patients Receiving Cancer Treatment in Zimbabwe | NIH | National Institute of Mental Health | 2023 to 2025 | $519,621 | June 1, 2023 | May 31, 2028 | MONTANO, MICHALINA | reporter.nih.gov |
| Integrating T cell receptor features with gene expression profiles to define T cell specificity and differentiation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $511,219 | February 1, 2022 | January 31, 2025 | BRADLEY, PHILIP | reporter.nih.gov |
| Erythrocyte fatty acids and risk of endometriosis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $506,118 | September 22, 2022 | August 31, 2025 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Statistical Methods for Precision Prevention | NIH | National Cancer Institute | 2025 | $505,613 | December 4, 2024 | November 30, 2029 | HSU, LI | reporter.nih.gov |
| Epitranscriptomic control of erythropoiesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $502,640 | September 17, 2019 | May 31, 2024 | PADDISON, PATRICK | reporter.nih.gov |
| Air pollution and health disparities in liver disease and cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $500,531 | July 15, 2020 | May 31, 2026 | VOPHAM, TRANG | reporter.nih.gov |
| From one end to the other: dynamics of human translation initiation and its control | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $498,000 | January 1, 2022 | August 31, 2026 | LAPOINTE, CHRISTOPHER PAUL | reporter.nih.gov |
| Promoting Genetic Counseling among African American Women with Hereditary Risk for Breast Cancer | NIH | National Cancer Institute | 2022 to 2024 | $488,554 | October 16, 2021 | May 31, 2025 | HENDERSON, VIDA ANN | reporter.nih.gov |
| Improving treatment of cardiovascular risk factors in childhood cancer survivors | NIH | National Cancer Institute | 2021 | $487,899 | March 1, 2017 | February 29, 2024 | CHOW, ERIC JESSEN | reporter.nih.gov |
| Propagation of graft vs. host disease through CD4+ T-cell cognate recognition of gastrointestinal microbiota | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $487,296 | July 1, 2023 | June 30, 2028 | YEH, ALBERT CHIA-CHUN | reporter.nih.gov |
| Optimizing the Efficacy and Safety of CD33-Targeted Immunotherapy for Acute Myeloid Leukemia and Other CD33+ Disorders | NIH | National Cancer Institute | 2023 to 2025 | $485,634 | August 15, 2023 | July 31, 2028 | LASZLO, GEORGE S | reporter.nih.gov |
| Evolution and mechanism of restriction of herpesviruses by MxB | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $484,000 | August 21, 2023 | July 31, 2026 | GEBALLE, ADAM P. | reporter.nih.gov |
| Defining mechanisms that underlie well-controlled translation initiation | NIH | National Institute of General Medical Sciences | 2025 | $484,000 | September 1, 2025 | August 31, 2030 | LAPOINTE, CHRISTOPHER PAUL | reporter.nih.gov |
| Mapping and Prediction of Epistatic Enhancer Interactions in Gene Regulation | NIH | National Institute of General Medical Sciences | 2025 | $484,000 | September 15, 2025 | July 31, 2030 | LIN, XUEQIU | reporter.nih.gov |
| eDyNAmiC - FREDHUTCH | NIH | National Cancer Institute | 2022 to 2025 | $479,995 | June 1, 2025 | May 31, 2026 | MALIK, HARMIT S. | reporter.nih.gov |
| Viral gene drive as a novel curative therapy for HSV infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $474,761 | February 21, 2024 | December 31, 2025 | WALTER, MARIUS | reporter.nih.gov |
| Discovery of sensorimotor connectivity mechanisms in a continuous topographic map | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $464,987 | February 1, 2022 | January 31, 2025 | MOENS, CECILIA B | reporter.nih.gov |
| Risk factors for and consequences of endometriosis among Black women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $461,320 | July 23, 2024 | June 30, 2027 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Integrating health informatics in a scalable stepped care self-management program for survivors after hematopoietic cell transplantation | NIH | National Cancer Institute | 2022 | $459,965 | May 1, 2017 | November 30, 2023 | BAKER, KEVIN S | reporter.nih.gov |
| Characterization of a new CXCR4-specific restriction factor | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $457,600 | August 1, 2024 | June 30, 2027 | OVERBAUGH, JULIE M. | reporter.nih.gov |
| An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology. | NIH | National Cancer Institute | 2022 | $456,691 | December 12, 2017 | November 30, 2023 | KEMP, CHRISTOPHER J | reporter.nih.gov |
| CD117-Targeted Radioimmunotherapy with Astatine-211 for Acute Myeloid Leukemia and Myelodysplastic Syndrome | NIH | National Cancer Institute | 2022 to 2023 | $455,366 | August 1, 2022 | July 31, 2025 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Ontogeny and Function of Early-Life Pulmonary Dendritic Cells | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $453,536 | February 10, 2023 | January 31, 2025 | HEADLEY, MARK BRYAN | reporter.nih.gov |
| Targeting Tregs in the solid tumor microenvironment by modulating metabolite signaling | NIH | National Cancer Institute | 2024 | $452,544 | July 1, 2024 | June 30, 2026 | KINSELLA, SINÉAD | reporter.nih.gov |
| Targeting alloantigen presentation in bone marrow to enhance graft-versus-leukemia effects | NIH | National Cancer Institute | 2024 to 2025 | $452,540 | January 1, 2024 | December 31, 2025 | KOYAMA, MOTOKO | reporter.nih.gov |
| Statistical Methods to Leverage Immunologic Biomarkers and Complex Molecular Testing Data for Respiratory Diseases Vaccines Development | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $448,573 | August 1, 2025 | July 31, 2030 | ZHANG, BO | reporter.nih.gov |
| Defining BCR evolution during immunization | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $448,553 | December 1, 2012 | May 31, 2023 | STAMATATOS, LEONIDAS | reporter.nih.gov |
| In vivo innate immune sensing of HIV-1 infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $445,254 | August 1, 2024 | June 30, 2027 | RONGVAUX, ANTHONY | reporter.nih.gov |
| Gastrointestinal microbiota interactions modulating gastric cancer progression | NIH | National Cancer Institute | 2022 to 2023 | $443,177 | July 1, 2022 | June 30, 2024 | SALAMA, NINA | reporter.nih.gov |
| A Prostate Cancer Dependency Map to Identify Tumor Subtype-Specific Vulnerabilities | NIH | National Cancer Institute | 2023 to 2024 | $442,255 | February 1, 2023 | January 31, 2025 | NELSON, PETER S | reporter.nih.gov |
| Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer Survivors | NIH | National Cancer Institute | 2023 to 2024 | $441,496 | July 1, 2023 | June 30, 2025 | CHOW, ERIC JESSEN | reporter.nih.gov |
| Optimizing pre-analytical variables for reliable mass spectrometry-based quantification of immunomodulatory proteins in cerebrospinal fluid in pediatric neuro-oncology trials | NIH | National Cancer Institute | 2025 | $440,171 | March 19, 2025 | February 28, 2030 | PAULOVICH, AMANDA G | reporter.nih.gov |
| Diversity Supplement: Uncovering diverse genotype-phenotype relationships in prostate cancer | NIH | National Cancer Institute | 2021 to 2022 | $433,099 | September 23, 2021 | August 31, 2024 | LEE, JOHN KYUNG | reporter.nih.gov |
| HIV persistence and treatment response in Kaposi sarcoma | NIH | National Cancer Institute | 2025 | $432,098 | August 4, 2025 | July 31, 2027 | WARREN, EDUS HOUSTON | reporter.nih.gov |
| Statistical methods for elucidating regulatory mechanisms and functional impacts of transcriptome variation at population and single-cell scales | NIH | National Institute of General Medical Sciences | 2025 | $425,463 | June 1, 2021 | May 31, 2027 | LI, JINGYI JESSICA | reporter.nih.gov |
| Regulation of cell migration and signaling by phosphotyrosine and ubiquitin | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $425,208 | August 1, 2014 | August 31, 2023 | COOPER, JONATHAN A | reporter.nih.gov |
| The impact of HIV on the breast cancer tumor microenvironment | NIH | Fogarty International Center | 2021 to 2022 | $424,226 | August 16, 2021 | July 31, 2025 | MENON, MANOJ P | reporter.nih.gov |
| Discovery and Characterization of Capsid-Targeting Lentiviral Restriction Factors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $418,011 | June 14, 2019 | July 31, 2022 | OHAINLE, MOLLY | reporter.nih.gov |
| The microbiome ecosystem of Barrett's esophagus and progression to cancer | NIH | National Cancer Institute | 2022 to 2023 | $407,287 | July 1, 2022 | June 30, 2025 | PAULSON, THOMAS G | reporter.nih.gov |
| Simulating persistence and elimination of the HIV reservoir | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $399,410 | August 1, 2020 | July 31, 2025 | REEVES, DANIEL | reporter.nih.gov |
| Assessing Helicobacter pylori and Diet to Develop Cancer Interventions in American Indian Communities in the Southwest | NIH | National Cancer Institute | 2022 to 2025 | $383,310 | September 4, 2020 | August 31, 2026 | PETE, DORNELL | reporter.nih.gov |
| Frontiers in Cancer Research | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $380,511 | August 1, 2018 | June 30, 2024 | CHOWNING, JEANNE TING | reporter.nih.gov |
| Personalized cancer models to discover and develop new therapeutic targets. | NIH | National Cancer Institute | 2021 | $378,822 | September 14, 2017 | August 31, 2023 | KEMP, CHRISTOPHER J | reporter.nih.gov |
| Fred Hutch Preclinical Ultrasound | NIH | Office of the Director, National Institutes of Health | 2022 | $373,050 | August 15, 2022 | August 14, 2023 | BERONJA, SLOBODAN | reporter.nih.gov |
| Predicting PrEP Uptake and Adherence among Adolescent Girls and Young Women in Sub-Saharan Africa: Leveraging Programmatic and Clinical Trials Data | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $371,881 | August 1, 2017 | June 30, 2024 | DUERR, ANN C | reporter.nih.gov |
| Predicting transcriptional signatures and tumor subtypes from circulating tumor DNA | NIH | National Cancer Institute | 2021 to 2022 | $370,065 | September 10, 2021 | August 31, 2023 | HA, GAVIN | reporter.nih.gov |
| Germline Genetics and Risk of Prostate Cancer in Diverse Populations from the All of Us Program | NIH | National Cancer Institute | 2023 to 2024 | $367,807 | September 19, 2023 | August 31, 2025 | DARST, BURCU FRANCES | reporter.nih.gov |
| Statistical Methods for Evaluating Markers for Treatment Selection | NIH | National Cancer Institute | 2021 | $358,007 | July 1, 2010 | November 30, 2023 | JANES, HOLLY | reporter.nih.gov |
| Assessing how multilevel factors shape disparities in cancer screening | NIH | National Cancer Institute | 2023 to 2024 | $342,900 | February 1, 2023 | November 30, 2025 | DEL VECCHIO, NATALIE | reporter.nih.gov |
| Research Specialist in Cancer Genomics to Integrate Basic Research and Clinical Data | NIH | National Cancer Institute | 2023 to 2025 | $338,919 | August 15, 2023 | July 31, 2028 | COLEMAN, ILSA | reporter.nih.gov |
| Using Single-cell and Spatial Multi-omics to Improve Adoptive Cell Therapy against Pancreatic Cancer | NIH | National Cancer Institute | 2024 to 2025 | $338,688 | September 1, 2024 | December 31, 2026 | SU, YAPENG | reporter.nih.gov |
| Investigating gastric inflammation and preneoplastic progression driven by Helicobacter pylori infection | NIH | National Cancer Institute | 2022 to 2023 | $335,664 | July 7, 2022 | July 31, 2023 | O'BRIEN, VALERIE PHOEBE | reporter.nih.gov |
| Modeling to Minimize Detection Bias in Cancer Risk Prediction Studies | NIH | National Cancer Institute | 2021 | $330,551 | September 19, 2019 | August 31, 2022 | ETZIONI, RUTH D | reporter.nih.gov |
| Statistical Methods for T Cell Receptor (TCR) Analysis | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $330,000 | June 23, 2022 | May 31, 2024 | SUN, WEI | reporter.nih.gov |
| Targeting Nrf2 for Cancer Chemoprevention | NIH | National Cancer Institute | 2021 | $316,253 | July 1, 2018 | July 31, 2022 | KENSLER, THOMAS W | reporter.nih.gov |
| Niche signals in HSC genesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $310,319 | September 1, 2017 | June 30, 2023 | BERNSTEIN, IRWIN D | reporter.nih.gov |
| Investigating the metastatic drive in pancreas cancer | NIH | National Cancer Institute | 2021 to 2022 | $306,378 | August 9, 2018 | November 30, 2022 | HINGORANI, SUNIL R | reporter.nih.gov |
| Annual HVTN Translational HIV Early Stage Investigator (ESI) Conference | NIH | Office of the Director, National Institutes of Health | 2022 to 2025 | $299,996 | April 7, 2017 | March 31, 2028 | KUBLIN, JAMES G. | reporter.nih.gov |
| Red and Processed Meat Effects on the Metabolome and Microbiome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $298,083 | May 21, 2021 | April 30, 2024 | NEUHOUSER, MARIAN L | reporter.nih.gov |
| Development of an anti-idiotype based vaccine for respiratory syncytial virus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $295,971 | June 1, 2021 | May 31, 2023 | MCGUIRE, ANDREW | reporter.nih.gov |
| An mHealth mood management tool to improve population-level tobacco cessation | NIH | National Institute on Drug Abuse | 2021 to 2022 | $289,226 | August 1, 2020 | June 30, 2024 | HEFFNER, JAIMEE | reporter.nih.gov |
| Optimizing NK Cell-Engaging Bispecific Antibody Therapy Targeting CD33 | NIH | National Cancer Institute | 2021 to 2022 | $285,208 | July 1, 2021 | June 30, 2024 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Maternal-infant Virome Transmission: the role of HIV and Antiretroviral Therapy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $276,765 | September 6, 2017 | June 30, 2023 | LEHMAN, DARA ANN | reporter.nih.gov |
| MegaTALS: hyperspecific reagents for targeted gene modification and correction | NIH | National Institute of General Medical Sciences | 2022 | $276,714 | February 1, 2014 | August 31, 2023 | STODDARD, BARRY L. | reporter.nih.gov |
| Reducing Inequities by Promoting Participatory Learning Experiences in Science (RIPPLES) | NIH | National Institute of General Medical Sciences | 2024 | $270,000 | May 1, 2024 | March 31, 2025 | CHOWNING, JEANNE TING | reporter.nih.gov |
| Overcoming stromal barriers to therapeutics in pancreas cancer | NIH | National Cancer Institute | 2022 | $265,568 | September 22, 2011 | December 31, 2022 | HINGORANI, SUNIL R | reporter.nih.gov |
| Environmental Exposures and Disparities in Sleep Health | NIH | National Heart, Lung, and Blood Institute | 2025 | $257,400 | September 19, 2025 | August 31, 2027 | VOPHAM, TRANG | reporter.nih.gov |
| Innate immune factors governing restriction of human coronaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $257,148 | August 1, 2022 | June 30, 2025 | STODDARD, CAITLIN | reporter.nih.gov |
| Disrupting the immune and drug-privileged microenvironment in pancreas cancer | NIH | National Cancer Institute | 2021 | $257,096 | September 30, 2017 | August 31, 2022 | HINGORANI, SUNIL R | reporter.nih.gov |
| Development of anti-PD-1-targeted chimeric antigen receptors and genetic circuits to deplete viral reservoirs in the nonhuman primate model of lentiviral infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $256,500 | August 5, 2024 | July 31, 2027 | EICHHOLZ, KARSTEN | reporter.nih.gov |
| Functional consequences of evolutionary innovation in histone repertoires | NIH | National Institute of General Medical Sciences | 2023 to 2024 | $250,000 | April 1, 2023 | March 31, 2025 | RAMAN, PRAVRUTHA | reporter.nih.gov |
| Visualizing transcription factor binding and chromatin assembly on newly synthesized DNA | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $250,000 | December 1, 2023 | November 30, 2025 | WOOTEN, MATTHEW | reporter.nih.gov |
| Harnessing Exercise to Enhance Immunity and Boost Immunotherapy Outcomes in Patients with Lung Cancer | NIH | National Cancer Institute | 2025 | $249,000 | February 1, 2024 | June 30, 2028 | KANG, DONG-WOO | reporter.nih.gov |
| Molecular Mechanisms That Control the Quality of Synaptic Vesicle Recycling | NIH | National Institute of General Medical Sciences | 2021 | $238,130 | July 1, 2018 | March 31, 2023 | BAI, JIHONG | reporter.nih.gov |
| Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer | NIH | National Cancer Institute | 2021 | $234,777 | June 14, 2017 | May 31, 2023 | CLURMAN, BRUCE E | reporter.nih.gov |
| The Brain and Maternal Microchimerism | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $231,782 | April 1, 2021 | March 31, 2023 | NELSON, J. LEE | reporter.nih.gov |
| Joint Analysis of Microbiome and Other Genomic Data Types | NIH | National Institute of General Medical Sciences | 2021 | $220,371 | September 1, 2018 | May 31, 2023 | WU, MICHAEL CHIAO-AN | reporter.nih.gov |
| Structure-Based Designs of HIV-1 Immunogens Targeting Germline Precursors of Broadly Neutralizing Antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $220,000 | March 17, 2021 | February 29, 2024 | PANCERA, MARIE | reporter.nih.gov |
| Clonal lineage tracing of HIV specific NK memory cells | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $220,000 | May 22, 2025 | April 30, 2027 | OVERBAUGH, JULIE M. | reporter.nih.gov |
| Targeting the DNA Damage Response in HPV+ Head and Neck Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $212,483 | July 1, 2021 | August 24, 2023 | DIAB, AHMED MOHAMED | reporter.nih.gov |
| Immunogenetic determinants of HSV-2 infection and disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $208,907 | June 1, 2020 | May 31, 2023 | LUND, JENNIFER M | reporter.nih.gov |
| Infection prevention strategies after CAR-T cell therapy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $205,901 | September 3, 2025 | August 31, 2030 | HILL, JOSHUA AIDEN | reporter.nih.gov |
| RAPID: A comparative online simulation tool for COVID-19 vaccine allocation | NSF | Division Of Environmental Biology | 2022 | $199,295 | February 1, 2022 | January 31, 2024 | Laura Matrajt | nsf.gov |
| Addressing Obesity to Reduce Cancer Risk and Health Disparities in Underserved Populations | NIH | National Cancer Institute | 2022 to 2024 | $196,854 | August 1, 2020 | September 14, 2024 | ZHANG, XIAOCHEN | reporter.nih.gov |
| B cell dynamics and immune memory formation in human vaccination | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $190,944 | August 8, 2025 | July 31, 2027 | GLASS, DAVID RICHARD | reporter.nih.gov |
| (PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa | NIH | National Cancer Institute | 2021 | $190,771 | May 11, 2017 | April 30, 2023 | WARREN, EDUS HOUSTON | reporter.nih.gov |
| Diet and the colonic exfoliome: a novel, non-invasive approach to testing interventions in humans | NIH | National Cancer Institute | 2021 | $190,520 | January 1, 2020 | December 31, 2023 | LAMPE, JOHANNA W | reporter.nih.gov |
| Identifying driver non-coding alterations in metastatic prostate cancer from tumor and cell-free DNA | NIH | National Cancer Institute | 2022 | $189,432 | April 1, 2020 | March 31, 2023 | HA, GAVIN | reporter.nih.gov |
| The structural and functional basis of MET exon 14 activation and acquired drug resistance | NIH | National Cancer Institute | 2023 | $182,223 | April 1, 2019 | March 31, 2025 | COLLISSON, ERIC | reporter.nih.gov |
| Mechanisms of Pip4k2c and Pip5k1b dependencies in Ras driven squamous cell carcinoma | NIH | National Center for Advancing Translational Sciences | 2023 | $176,000 | June 1, 2023 | May 31, 2025 | KEMP, CHRISTOPHER J | reporter.nih.gov |
| Understanding the pathogenesis of classic Hodgkin lymphoma in persons living with HIV through conventional and spatial transcriptomics | NIH | National Cancer Institute | 2024 | $176,000 | August 8, 2024 | July 31, 2026 | NARESH, KIKKERI | reporter.nih.gov |
| Type II diabetes, related biomarkers and medications, and ovarian cancer risk | NIH | National Cancer Institute | 2022 to 2023 | $175,999 | February 1, 2022 | January 31, 2025 | HARRIS, HOLLY RUTH | reporter.nih.gov |
| Culturally Competent Communication Intervention to Improve Latinos' Engagement in Advance Care Planning | NIH | National Cancer Institute | 2021 | $172,260 | July 1, 2017 | April 30, 2025 | SHEN, MEGAN JOHNSON | reporter.nih.gov |
| Roles and regulation of polyamines during HCMV infection | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $170,886 | December 1, 2020 | November 30, 2023 | GEBALLE, ADAM P. | reporter.nih.gov |
| Unraveling myeloid-mediated mechanisms of immunotherapy resistance in prostate cancer bone metastases at single-cell resolution | NIH | National Cancer Institute | 2025 | $169,776 | August 1, 2025 | July 31, 2027 | LYU, ARAM | reporter.nih.gov |
| Mechanisms regulating nuclear envelope structure and stability | NIH | National Institute of General Medical Sciences | 2021 | $167,652 | August 1, 2017 | December 31, 2022 | HATCH, EMILY M | reporter.nih.gov |
| Delineating the mechanisms and clinical utility of mtDNA mutagenesis in cancer | NIH | National Cancer Institute | 2021 | $161,299 | February 15, 2017 | January 31, 2023 | HOCKENBERY, DAVID M. | reporter.nih.gov |
| Ubiquitin-mediated regulation of kinetochore assembly and function | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $155,348 | September 1, 2024 | August 31, 2027 | FRANK, ANDERSON ROSS | reporter.nih.gov |
| Investigating the chromatin landscape of complex tissues through cell-type-specific patterns | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $149,348 | January 1, 2024 | December 31, 2026 | LEICHTER, SARAH | reporter.nih.gov |
| Developmental mechanisms specifying vagal innervation of organ targets | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $147,540 | January 1, 2024 | December 31, 2026 | SEROKA, AUSTIN | reporter.nih.gov |
| Mechanisms of Target-Specific Axon Regeneration | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $142,118 | December 15, 2021 | February 27, 2023 | ISABELLA, ADAM JAMES | reporter.nih.gov |
| Enriching Neuro-Oncology Survivorship: A Novel Symptom Management Education to Living Fully (SELF) | NIH | National Cancer Institute | 2025 | $140,854 | July 1, 2025 | December 31, 2026 | FIGURACION, KARL CRISTIE F | reporter.nih.gov |
| Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 | NIH | National Cancer Institute | 2023 | $140,086 | April 1, 2019 | June 30, 2025 | COLLISSON, ERIC | reporter.nih.gov |
| The RNA components of the translation apparatus in prostate cancer plasticity and therapy response | NIH | National Cancer Institute | 2025 | $139,184 | July 1, 2025 | June 30, 2027 | KIM, YEON SOO | reporter.nih.gov |
| Improving cancer survivorship care delivery in Latino survivors: telehealth & lay health educators | NIH | National Cancer Institute | 2021 | $136,965 | September 21, 2021 | August 31, 2024 | CHOW, ERIC JESSEN | reporter.nih.gov |
| Bridging the gap: joint modeling of single-cell 1D and 3D genomics | NIH | National Human Genome Research Institute | 2023 to 2024 | $132,424 | August 1, 2023 | September 1, 2024 | ZHENG, YE | reporter.nih.gov |
| Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance | NIH | National Cancer Institute | 2021 | $131,912 | September 18, 2019 | August 31, 2023 | LIN, DANIEL W. | reporter.nih.gov |
| Computational Strategies for Deciphering Cellular Differentiation and Cancer Progression | NIH | National Institute of General Medical Sciences | 2025 | $129,708 | August 1, 2025 | July 31, 2026 | OTTO, DOMINIK JENZ | reporter.nih.gov |
| Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $129,445 | February 7, 2020 | July 31, 2023 | PRLIC, MARTIN | reporter.nih.gov |
| Functional and antigenic evolution of SARS-related coronaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $128,574 | June 10, 2022 | May 31, 2023 | STARR, TYLER NELSON | reporter.nih.gov |
| Regulatory T cell coordination of the mucosal NK cell response during viral infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $128,250 | June 14, 2024 | May 31, 2025 | VICK, SARAH C | reporter.nih.gov |
| Biology and therapy of C11orf95-RELA fusion-driven ependymoma | NIH | National Cancer Institute | 2022 | $125,104 | September 19, 2019 | August 31, 2025 | HOLLAND, ERIC C. | reporter.nih.gov |
| Consequence of human satellite repeat expression and immunostimulatory potential in FSHD | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $124,308 | September 15, 2025 | August 31, 2027 | ARENDS, TESSA AMANDA | reporter.nih.gov |
| Collaborative Research: ReDDDoT Phase 2: Enabling Participatory Privacy Protections for AI Training Data | NSF | Emerging Technologies Section | 2024 | $120,511 | October 1, 2024 | September 30, 2027 | Sean Kross | nsf.gov |
| Advanced genetic systems for Fusobacterium nucleatum in oral and extra-oral pathologies | NIH | National Institute of Dental & Craniofacial Research | 2023 | $119,645 | September 19, 2023 | May 1, 2024 | JOHNSTON, CHRISTOPHER D | reporter.nih.gov |
| Reactivation of an early embryonic program in FSHD and cancer | NIH | National Cancer Institute | 2022 to 2023 | $115,698 | December 1, 2020 | November 30, 2023 | HAMM, DANIELLE | reporter.nih.gov |
| Optimization of Siglec-8-Directed Immunotherapy for Eosinophilic and Mast Cell Disorders | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $113,858 | April 1, 2020 | March 31, 2023 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| NCI PATTERNS OF CARE STUDY: (DIAGNOSIS YEAR 2020 BREAST CANCER AND COLORECTAL CANCER) | NIH | National Cancer Institute | 2023 | $109,264 | December 23, 2022 | December 22, 2023 | SCHWARTZ, PHD, STEPHEN | reporter.nih.gov |
| Tailoring Therapy to Pancreatic Cancer Subtypes | NIH | National Cancer Institute | 2022 | $107,887 | August 1, 2018 | December 31, 2025 | COLLISSON, ERIC | reporter.nih.gov |
| Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers | NIH | National Cancer Institute | 2021 | $107,543 | July 1, 2017 | June 30, 2022 | STEPHAN, MATTHIAS | reporter.nih.gov |
| NCI PATTERNS OF CARE STUDY - DIAGNOSIS YEAR 2021 (PROSTATE CANCER AND OVARIAN CANCER) | NIH | National Cancer Institute | 2024 | $104,718 | May 1, 2024 | April 30, 2025 | SCHWARTZ, STEPHEN M | reporter.nih.gov |
| Identifying relevant HLA-F ligands | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $104,516 | June 1, 2020 | August 31, 2022 | STRONG, ROLAND K | reporter.nih.gov |
| Genome-wide mechanisms and dynamics of ATP-dependent chromatin remodeling complexes | NIH | National Institute of General Medical Sciences | 2022 | $99,999 | April 1, 2021 | March 31, 2023 | BRAHMA, SANDIPAN | reporter.nih.gov |
| Mechanisms of Metastasis Suppression in the Spleen | NIH | National Cancer Institute | 2025 | $99,014 | September 1, 2024 | July 31, 2029 | PRIMEAUX, MARK | reporter.nih.gov |
| CAR T-Cell Therapy Targeting the Membrane-Proximal C2-Set Domain of CD33 for Treatment of Acute Myeloid Leukemia and Other CD33-Expressing Hematopoietic Neoplasms | NIH | National Cancer Institute | 2021 | $89,514 | December 10, 2019 | November 30, 2023 | WALTER, ROLAND BRUNO | reporter.nih.gov |
| Neural basis of movement in health and disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $89,360 | September 15, 2023 | September 14, 2025 | HASSINAN, CERA | reporter.nih.gov |
| Structural Mechanism of Activation and Modulation of Tie2-mediated Angiogenesis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $89,062 | September 1, 2024 | August 31, 2027 | NGUYEN, ADAM | reporter.nih.gov |
| Improving engineered TCR-T cell therapy for solid tumors by targeting Tcf1+ stem-like reservoirs in tumor-draining lymph nodes | NIH | National Cancer Institute | 2024 to 2025 | $88,872 | August 16, 2024 | August 15, 2026 | NUTT, WILLIAM SAMUEL | reporter.nih.gov |
| HLA at the Interface of Self and Other During Pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $88,000 | April 14, 2021 | March 31, 2023 | NELSON, J. LEE | reporter.nih.gov |
| In vivo mechanisms for integration of contextual information | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $87,390 | September 1, 2023 | August 31, 2025 | ROSERO, MANUEL | reporter.nih.gov |
| Optimizing myeloma-specific immunity after autologous stem cell transplantation | NIH | National Cancer Institute | 2022 | $84,415 | September 25, 2019 | August 31, 2024 | HILL, GEOFFREY ROGER | reporter.nih.gov |
| Defining novel genetic dependencies in spliceosome mutant leukemia | NIH | National Cancer Institute | 2022 | $77,497 | December 1, 2019 | November 30, 2022 | LEE, STANLEY CHUN-WEI | reporter.nih.gov |
| Regulatory mechanisms linking protein synthesis and degradation | NIH | National Institute of General Medical Sciences | 2025 | $75,520 | September 1, 2025 | August 31, 2027 | YELLAND, JAMES | reporter.nih.gov |
| Exploring the molecular mechanisms controlling CDK7i sensitivity in pancreas cancer | NIH | National Cancer Institute | 2024 | $74,284 | July 1, 2024 | June 30, 2026 | WALLACE-POVIRK, ADRIANNE | reporter.nih.gov |
| Elucidating how a USP9X-COP1 axis regulates RIT1 protein abundance and reveals druggable targets in lung adenocarcinoma | NIH | National Cancer Institute | 2022 to 2023 | $74,001 | August 1, 2022 | March 15, 2024 | RILEY, AMANDA | reporter.nih.gov |
| Molecular mechanisms underlying neuronal integrity | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $67,645 | January 1, 2021 | November 30, 2023 | JIMENEZ, MONET A. | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE (WHI) | NIH | National Heart, Lung, and Blood Institute | 2022 | $67,100 | July 12, 2022 | August 12, 2022 | NGUYEN, VAN | reporter.nih.gov |
| Can a subset of patients with HER2+ metastatic breast cancer be cured? | NIH | National Cancer Institute | 2025 | $63,225 | April 1, 2021 | April 30, 2027 | PARSONS, HEATHER ANNE | reporter.nih.gov |
| Defining and targeting mechanisms of pancreas cancer pathogenesis | NIH | National Cancer Institute | 2021 | $61,431 | September 19, 2017 | August 31, 2022 | WHITTLE, MARTIN | reporter.nih.gov |
| Cell-intrinsic effectors of the antiviral interferon response against HIV in primary human samples | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $61,041 | September 16, 2022 | December 15, 2023 | ITELL, HANNAH | reporter.nih.gov |
| FINALIZED INDIRECT AND FRINGE RATES FOR 2016-2017 | NIH | National Heart, Lung, and Blood Institute | 2022 | $56,248 | September 20, 2022 | October 19, 2022 | NGYUEN, VAN | reporter.nih.gov |
| (PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states. | NIH | National Cancer Institute | 2021 | $53,196 | September 21, 2017 | June 30, 2023 | GRADY, WILLIAM MALLORY | reporter.nih.gov |
| HSV-2 specificity and phenotyping of tissue-based T cells in genital skin biopsies of HSV-2 reactivation | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $51,775 | February 1, 2020 | June 30, 2022 | FORD, EMILY | reporter.nih.gov |
| Elucidating the role of somatic 3’UTR mutations in prostate cancer pathogenesis | NIH | National Cancer Institute | 2022 to 2023 | $49,078 | March 1, 2021 | June 9, 2023 | SCHUSTER, SAMANTHA LEE | reporter.nih.gov |
| Characterization of tumor-specific human endogenous retroviruses in clear cell Renal Cell Carcinoma | NIH | National Cancer Institute | 2025 | $46,368 | September 16, 2025 | September 15, 2028 | KOGUT, SOPHIA | reporter.nih.gov |
| Epigenomic Dynamics of Clonal Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2025 | $44,945 | September 1, 2025 | August 31, 2027 | JORDAN, CAILIN | reporter.nih.gov |
| Deciphering the Dynamic Coordination of Chromatin Accessibility and Gene Expression to Uncover the Mechanisms of Cellular Differentiation | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $44,843 | July 1, 2025 | June 30, 2028 | FINKBEINER, CONNOR | reporter.nih.gov |
| The role of Fusobacterium in colorectal cancer treatment, tumor ecology and chemotherapeutic efficacy | NIH | National Cancer Institute | 2021 | $44,727 | August 1, 2019 | July 31, 2022 | BULLMAN, SUSAN | reporter.nih.gov |
| Necrosis-mediated circulating tumor cell dissemination | NIH | National Cancer Institute | 2022 to 2023 | $42,741 | March 1, 2022 | March 15, 2023 | YAMAMOTO, AMI | reporter.nih.gov |
| Statistical Methods for Evaluating and Guiding Implementation of New HIV Prevention Strategies | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $41,105 | August 15, 2019 | July 31, 2022 | JANES, HOLLY | reporter.nih.gov |
| Molecular impediments to fate-specifying pioneer factor activity during development | NIH | National Institute of General Medical Sciences | 2022 | $38,030 | March 3, 2021 | August 31, 2022 | MEERS, MICHAEL P | reporter.nih.gov |
| Quantifying the genetic and environmental factors driving avian influenza spillover | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $33,564 | July 6, 2020 | August 31, 2022 | MONCLA, LOUISE HILLIER | reporter.nih.gov |
| Biological and therapeutic consequences of RNA dysregulation in cancer immune evasion | NIH | National Cancer Institute | 2022 | $31,625 | July 14, 2022 | August 31, 2022 | THOMAS, JAMES DOUGLAS | reporter.nih.gov |
| Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $31,293 | July 15, 2020 | June 30, 2022 | SCHIFFER, JOSHUA TISDELL | reporter.nih.gov |
| Investigating the Role of DNA Repair Mutations in Prostate Cancer Initiation, Progression, and Susceptibility to Targeted Therapies | NIH | National Cancer Institute | 2021 | $31,177 | August 1, 2019 | July 31, 2022 | FRANK, SANDER BARKLEY | reporter.nih.gov |
| Defining the role of C. elegans Parkin/PDR-1 in glial engulfment of neuron fragments | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $29,198 | March 1, 2021 | August 31, 2022 | RAIDERS, STEPHAN | reporter.nih.gov |
| Flow Cytometry Training Workshop 2021-22 | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $25,000 | August 6, 2021 | July 31, 2023 | ANDERSEN-NISSEN, ERICA | reporter.nih.gov |
| Advancing Breast Health in Uganda | NIH | National Cancer Institute | 2022 | $25,000 | September 20, 2022 | August 31, 2023 | SCHEEL, JOHN R | reporter.nih.gov |
| Flow Cytometry Workshops in Africa | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $25,000 | December 1, 2024 | November 30, 2029 | ANDERSEN-NISSEN, ERICA | reporter.nih.gov |
| Evolutionary dynamics of antibody affinity maturation | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $20,106 | January 1, 2020 | May 1, 2022 | DEWITT, WILLIAM S. | reporter.nih.gov |
| Mechanisms and consequences of cytoskeletal control of Helicobacter pylori cell shape | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $6,459 | August 1, 2020 | June 30, 2022 | SICHEL, SOPHIE R. | reporter.nih.gov |
| Elucidating the mechanisms of kinetochore assembly initiation | NIH | National Institute of General Medical Sciences | 2021 | $5,161 | May 1, 2020 | April 30, 2022 | POPCHOCK, ANDREW R | reporter.nih.gov |
| ANAEROBE 2022: the 16th Biennial Congress of the Anaerobe Society of the Americas (ASA) | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $5,000 | June 22, 2022 | May 31, 2023 | FREDRICKS, DAVID NEAL | reporter.nih.gov |
| Innate immune factors governing restriction of human coronaviruses | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1 | August 1, 2022 | September 2, 2025 | STODDARD, CAITLIN | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 247 | $369,699,126 | 0 | $0 |
| 2024 | 252 | $304,599,122 | 1 | $120,511 |
| 2023 | 262 | $352,662,706 | 0 | $0 |
| 2022 | 256 | $414,249,129 | 1 | $199,295 |
| 2021 | 151 | $52,180,478 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | May 7, 2027 | Not listed | Notice number printed on 5 awards here | |
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 5 awards here | |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | November 24, 2026 | Not listed | Notice number printed on 1 award here | |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | May 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 94 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 94 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 94 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 94 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 94 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 94 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 94 awards here |
Topics of its NIH awards
- Cancer
- Genetics
- Clinical Research
- Prevention
- Biotechnology
- Rare Diseases
- Infectious Diseases
- Translational Research
- Human Genome
- Clinical Trials and Supportive Activities
- Immunotherapy
- Hematology
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.